Position history for Capital Research Global Investors's holdings in GILEAD SCIENCES INC
Capital Research Global Investors holds 27.1M shares of GILD (GILEAD SCIENCES INC), worth $3.8B as of 2026-Q1. The position was increased (+7.2% shares). GILD represents 0.6% of Capital Research Global Investors's portfolio.
Current Value
$3.8B
Current Shares
27.1M
Total Value Change
-$365.2M
Total Shares Change
-33.3M
Other major holders of GILD: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 27.1M |
+7.2% |
| $3.8B |
| 0.6% |
| $147.83 |
48 |
| 2025-Q4 | Decreased | 25.3M | -15.7% | $3.1B | 0.6% | $123.18 | 0 |
| 2025-Q3 | Decreased | 30M | -3.5% | $3.3B | 0.6% | $111.88 | 0 |
| 2025-Q2 | Decreased | 31.1M | -43.1% | $3.4B | 0.7% | $109.19 | 0 |
| 2025-Q1 | Decreased | 54.6M | -5.8% | $6.1B | 1.3% | $109.51 | 0 |
| 2024-Q4 | Decreased | 57.9M | -6.2% | $5.4B | 1.1% | $89.51 | 0 |
| 2024-Q3 | Increased | 61.8M | +2.3% | $5.2B | 1.1% | $80.66 | 51 |
| 2024-Q2 | Decreased | 60.4M | -1.3% | $4.1B | 0.9% | $65.57 | 0 |